Objective: We retrospectively investigated the short and mid-term outcome of non-emergent primary isolated coronary artery bypass graft (CABG) surgery in relation to risk stratification in the fully equipped university location (FE) and the low volume, limited facility location (LVLF) of our department. Methods: Between September 1995 and December 1996, 832 patients were referred to our department to undergo a primary isolated CABG operation. The surgical team selected 482 patients (58%) as being at low-risk. These were treated in the LVLF hospital. The other 350 patients with mixed-risk were treated in the FE hospital. The selection consisted primarily of exclusion of patients with moderate or poor left ventricular function, severe COPD or renal impairment, from surgery in the LVLF location. Finally, the prognostic value of the EuroSCORE and the Parsonnet score was tested on our patient population. Results: Overall in-hospital mortality was 1.6% (13 patients). One patient died in the LVLF group (0.2%) and 12 patients (3.4%) in the FE group. LVLF patients experienced less complications during the hospital period compared to the FE patients (5 versus 21%; P ¼ 0:0001). The Parsonnet risk model and the EuroSCORE risk model showed both a good relation with in-hospital mortality. After discharge, an increased risk of late mortality was observed up to 1 year postoperative in the FE group compared to the LVLF group (2.7 versus 0.5%; P ¼ 0:01). Risk factors for 5-year mortality were pre-operative renal impairment (blood creatinine .150 mmol/l) (hazard ratio (HR): 2.8; 95% confidence interval (CI): 1.4-5.5), diabetes (HR: 2.1; 95% CI: 1.3-3.5), impaired LVEF (HR: 1.9; 95% CI: 1.2-3.0), COPD (HR: 1.9; 95% CI: 1.1-3.5) and older age (HR: 1.07 per year; 95% CI: 1.01-1.10). Lipid-lowering therapy was a predictor of lower mortality at 5-years (HR: 0.5; 95% CI: 0.4-0.9). Conclusion: By careful decision making, selection of low-risk patients for a low volume and limited facility location resulted in excellent in-hospital survival with very low complication rates. q
Introduction
Coronary artery bypass surgery (CABG) was first carried out more than 30 years ago [1] and rapidly became a routine operation for revascularization in patients with coronary artery disease. To meet the demands of such sudden increase, our cardiothoracic surgery team performs CABG in two locations. The primary location is the university hospital, which is fully equipped (FE) for all cardiothoracic surgery. In the second limited facility location a low volume, limited facility location program (LVLF) of weekly 6-8 non-emergent primary isolated coronary bypass operations are performed by members of the surgical staff of the university hospital, but only in patients who are selected as being at low-risk. No other cardiac surgery is done at this site. In order to investigate the results of CABG in our practice we followed 832 consecutive patients who underwent CABG surgery at these two locations and followed these patients up to 5 years. We determined the 5-year outcome with regard to mortality and coronary reinterventions and investigated potential predictors of both early and mid-term mortality.
The use of risk assessment models is now widespread. The Parsonnet risk stratification system [2] was developed in the USA in the 1980s and recently the European System for Cardiac Operative Risk Evaluation (EuroSCORE) has emerged [3] . The applicability of the Parsonnet score and the EuroSCORE models was tested retrospectively to our study population. emergent (elective or semi elective) primary isolated CABG operation (CABG without other open heart procedures during the same hospital admission). The 52 redo CABG operations that were performed in the FE location in this time frame were excluded. Also excluded were 23 patients referred for a non-elective procedure such as failed angioplasty or those who suffered an acute myocardial infarction in the 24 h prior to CABG, all of these patients were treated in the FE location. Of the remaining 832 patients, 482 (58%) were selected as being at low-risk and treated in the LVLF location. Low-risk patients were selected primarily by absence of the following risk factors: moderate or poor left ventricular function, severe COPD or elevated creatinine levels. However, no further strict decision rules or existing risk scores were used in this cohort. Baseline characteristics included the clinical profile, angina and functional status, risk factors and information on coronary angiographic features.
Fully equipped location versus low volume limited facility location
The cardiothoracic surgeon and perfusionist from the FE location performed the surgery, assisted by residents or a fellow in general surgery from the LVLF location. Limited material facilities and no prosthetic or valvular material are at hand in the LVLF location. After surgery the cardiothoracic surgeon is not present in the LVLF unit, but on call. There are no specific residents available. Patients stay in a general intensive care unit, seen by anesthesiologists. The ward is incorporated in the department of cardiology. The limited outpatient clinic is incorporated in the department of general surgery. If problems arise that are beyond the LVLF unit's abilities, sometimes the necessary expertise and material is transported from the FE location to the LVLF location, but mostly the patient is transported to the FE location for further treatment.
Surgical technique
Standard extracorporeal circulation with moderate hypothermia and cardioplegic arrest (St. Thomas solution) was used for the operations. An average of 2.8 distal coronary anastomoses per patient was made.
Follow-up
At the time of the follow-up, June 1 2001, follow-up status was obtained retrospectively by review of the hospital records and checked against the civil registries. Furthermore, general practitioners were approached for recording of myocardial infarctions, strokes and possible subsequent revascularizations that were not performed in our center. If no further information from the general practitioner could be obtained, the patients were approached after retrieval of vital status. The cause of death was determined by checking our hospital records or by contacting the referring hospitals or the treating general practitioner. With regard to the cause of death a distinction was made between cardiac death (sudden death ,1 h of complaints, fatal acute myocardial infarction, congestive heart failure) and non-cardiac death (all other causes). In eight of the 92 patients who died (9%) the cause of death could not be retrieved. In three patients who had moved abroad, survival status could not be retrieved and the last available follow-up data were used. Follow-up was complete in all other patients (99.5%).
Risk assessment
We tested the established Parsonnet [2] and the Euro-SCORE [3] risk assessment models on our study population (Appendix). The Parsonnet model allocates additive predicted mortality percentage points to 14 patient risk factors to give a Parsonnet score, which is supposed to be indicative of the percent mortality for each patient. For the EuroSCORE model 68 preoperative risk factors and 29 operative variables were collected in 128 participating centers in 1995. This resulted in nine patient-related factors, four cardiac-related factors and four operation-related factors.
Statistical methods
Continuous data were expressed as mean valueŝ tandard deviation (SD) and were compared using Student's t-test, categorical variables by chi-square tests. Cumulative survival curves were constructed using the Kaplan-Meier method. Among patient subgroups the log-rank test was used to compare survival curves. A logistic multivariable regression, stratified by the two hospitals, was used to adjust for the baseline differences to determine the impact on inhospital mortality and hospital complications. Odds ratios and 95% confidence intervals were calculated to test for significant differences in early events between the two hospitals.
The following events were classified as in-hospital complications: acute myocardial infarction, cerebro vascular accident, prolonged artificial ventilation (.2 days), reanimation, rethoracotomy for bleeding, intra aortic balloon pump or reoperation for wound complication. To determine independent predictors of 1-and 5-year survival multivariate analysis was carried out using stepwise (forward and backward) Cox regression. Pre-selected variables were age, gender, diabetes (defined as pharmacologically treated; types I or II), treated hypertension, the use of medication for hypercholesterolemia, number of diseased vessels (stenosis .50%), qualitative left ventricular ejection fraction (normal if .55%; reduced if .45 and #55%; moderate if .30% and #45%; poor if #30%), chronic obstructive pulmonary disease (COPD; pharmacologically treated) and renal impairment (blood creatinine .150 mmol/l).
Results
In Table 1 preoperative patient characteristics are displayed for all patients, and separately for the FE location and the LVLF location. LVLF patients were almost 2 years younger compared to FE patients (63.8 years versus 62.0 years; P ¼ 0:01). The LVLF group contained relatively more patients with two vessel disease (28 versus 19%) and less patients with three vessel disease (56 versus 68%; P ¼ 0:01) and most patients had a normal ejection fraction (91 versus 47%; P ¼ 0:0001). Furthermore, fewer patients in the LVLF group had diabetes (13 versus 18%; P ¼ 0:04) and prior myocardial infarctions (44 versus 57%; P ¼ 0:001). Table 2 displays the procedural data of both hospitals. The surgical techniques were similar in both centers. Arterial grafts were used in 90% of the patients. The left internal mammary artery (LIMA) was used to graft the left anterior descending artery (LAD) in 75% of the patients. The right internal mammary artery (RIMA) was used in 6% and the gastric epiploica artery (GEA) in 3% of the patients. A combination of vein grafts and arterial grafts were used in the majority of the patients (81%). Exclusively vein grafts were used in 10% of the patients and exclusively arterial grafts in 9% of the patients. The main reasons for not using arterial grafts were the physical condition of the patients (26%), severe unstable angina (15%), poor left ventricular function (11%), renal failure (11%) or a left ventricular aneurysm (9%). The right coronary artery (RCA) and left circumflex (LCX) were grafted more often in the FE group because of the more extensive vessel disease in this patient group as evidenced by more distal anastomoses in this group (2.9 versus 2.7%; P ¼ 0:01). The T-graft procedure was used in 7% of the patients. Endarterectomy was performed in 15 FE patients of whom three died. One patient had a complicated and extensive postoperative period (2 months post-operative artificial ventilation) and died after 3 months. The other two patients died after 4 years from non-cardiac causes. All four LVLF patients in whom endarterectomy was performed were still alive at the end of the follow-up.
In-hospital outcome
According to the 1995/1996 protocol, in both locations most patients were discharged at day 11 after surgery. Table  3 outlines the clinical outcome during the hospital period. Overall in-hospital mortality was 1.6% (13 patients). One patient died in the LVLF group (0.2%) and 12 patients Wound complications (surgically treated) were also less frequent in the LVLF group (1 versus 4%; P ¼ 0:005) and an intra aortic balloon pump was needed in 15 patients (2%), of whom only two LVLF patients. Overall, the LVLF patients experienced less complications during the hospital period than the university patients did (5 versus 21%; P ¼ 0:0001). Although the hospital location was univariately predictive of in-hospital mortality (OR: 2.9; 95% CI: 1.8-4.7), this location was, after adjustment for all baseline variables, it was not significant anymore (OR: 1.9; 95% CI: 0.2-20.8).
Risk assessment hospital mortality
In Figs. 1 and 2 the distribution of the EuroSCORE and Parsonnet score are shown for both locations. Below a Euro-SCORE of 4 the LVLF patients dominated. With increasing EuroSCORE the FE patients were in the majority. A similar trend was seen for the Parsonnet score. In both models a good relation was observed with in-hospital mortality.
5-year outcome
The median follow-up duration was 62 months (range 54-70 months)with a total follow-up of 4191 patientyears. In total, 78 patients had died after CABG. After hospital discharge 65 patients died during follow-up (52% for cardiac reasons), of which 30 patients of the LVLF group and 35 patients of the FE group. Overall cumulative mortality at 5 years was 16% in the FE group and 8% in the LVLF group (Fig. 3) . During the 1st year after hospital discharge the FE patients had an increased mortality rate compared to the patients from the LVLF location (2.7 versus 0.5%). However, after the first operative year both survival curves run parallel and the yearly mortality rates were 2% in Table 3 In-hospital outcome a Total FE location LVLF location P-value During follow-up a repeat coronary intervention occurred in four patients. Of the FE group three patients underwent a second CABG, as did one patient from the LVLF group. Coronary angioplasty during this period was similar in both groups and occurred in 25 patients (3%). All these reinterventions occurred at least 1 year after initial surgery. During follow-up 21 patients had a myocardial infarction. This was similar in both groups. Fig. 4 shows cumulative event-free survival (freedom from death, myocardial infarction, CABG, PTCA or CVA). After the first operative year the two curves are running parallel. The 1-, 3-and 5-year event- free survival rates were, respectively, 95, 88 and 81% for the LVLF population and 89, 83 and 76% for the FE population (P ¼ 0:08).
Predictors of 1-and 5-year mortality
Independent risk factors of a higher 1-year cardiac mortality were impaired left ventricular ejection fraction (HR: 7.2; 95% CI: 2.8-18.0) and renal impairment (HR: 3.4; 95% CI: 1.3-9.2).
Independent risk factors of increased 5-year mortality were renal impairment (HR: 2.8; 95% CI: 1.4-5.5), diabetes (HR: 2.1; 95% CI: 1.3-3.5), impaired left ventricular ejection fraction (HR: 1.9; 95% CI: 1.2-3.0), COPD (HR: 1.9; 95% CI: 1.1-3.5) and higher age (HR: 1.07 per year; 95% CI: 1.01-1.10). Already at 5 years post-CABG it is evident that the use of only vein grafts is probably related to higher mortality (HR: 1.9; 95% CI: 0.95-3.8). Therapy for hyperlipidemia was an independent predictor of lower mortality (HR: 0.6; 95% CI: 0.4-0.9) ( Table 4 ).
Discussion
Both short-term and mid-term outcome of this 1995/1996 patients cohort who underwent CABG in our center is satis- Fig. 4 . Cumulative Kaplan-Meier event-free survival curves (freedom from death/MI/repeat CABGPTCA or CVA) according to the fully equipped location (FE) and LVLF location. The vertical lines represents the 95% confidence intervals (^2 SD). factory. Patients who underwent CABG in the LVLF location were indeed at very low risk of in-hospital mortality and morbidity. By careful decision making, selection of low-risk patients turned out to be adequate for a low volume and limited facility location. In-hospital mortality in this group was negligible with very low complication rates. According to the EuroSCORE risk assessment model most patients treated in the LVLF location were at low risk.
Despite large differences in patient-profile, the in-hospital mortality rate was similar compared to earlier series from our department of patients who underwent CABG in the 1970s (1.6 now versus 1.2% in the 1970s) [4] . Compared with other registries our in-hospital mortality results are below average. Lewsey et al. reported the Scottish Registry [5] results and found 2.7% mortality at 30-days in a similar patient subpopulation and Hannan et al. from the large New York Registry [6] reported an in-hospital mortality of 1.9% after primary elective CABG.
Only one of the 482 LVLF patients died before discharge and in only 5% complications occurred during admission. Only experienced surgeons were operating in the LVLF location. Although our group at that time did not use any established risk model, the decision to allocate the patients to the low-risk group, which could be referred to the LVLF location, turned out to be clinically very applicable.
Due to hospital strategies at that time (1995) and albeit the higher risk profile of the FE location patients, hospital stay was in both locations similar (11 days). Since then, the median hospital stay has decreased gradually.
Risk assessment models for in-hospital mortality
Jones et al. [7] defined and prioritized clinical variables to reflect their importance for relating to in-hospital mortality after CABG and concluded that only seven clinical variables already provided a large amount of prognostic information. Bridgewater et al. showed [8] that risk scores from the USA, or even from other European countries might have only limited predictive ability. Sergeant et al. [9] used a learning set from his own center of patients who operated between 1971 and 1987, and tested his formula on patients who operated between 1987 and 1992. A limitation of this model is that over time clinical criteria are changing and that the operations and knowledge are evolving. Retrospectively, we tested the Parsonnet score [2] and EuroSCORE [3] on our patient population. Both scores showed a good relation with in-hospital mortality. However, the total number of events was too low to draw conclusions. Therefore, we used both models only to illustrate the patients' risk profile.
Long-term outcome
We observed that patients from the FE location had an increased risk of mortality after hospital discharge the first postoperative year (n ¼ 10; 2.7%) (Fig. 3) . This finding is in agreement with Noyez et al. [10] who concluded that for risk assessment the in-hospital period is not sufficient, but should be expanded to at least 6 months. In contrast, the risk of mortality in the LVLF location patients remained constant directly after discharge throughout the end of the follow-up period (0.5%/year).
The mid-term prognosis up to 5 years was excellent. The yearly mortality rate after 1 year follow-up was only 1.5% in patients treated at the LVLF location and 2% for the FE patients, and this is similar to the normal Dutch population matched for age and sex (1.7%) (Fig. 3) . Coronary reintervention was rare in the first 5 years. According to an earlier report from our institution [4] higher intervention rates can be expected after the 8 years, mostly due to vein graft restenosis.
Predictors of mortality
In concordance with previous studies, we found that renal impairment, diabetes (types I or II), impaired left ventricular function, COPD and age were independent risk factors for higher mortality. Additionally to these findings hyperlipidemia was also an independent predictor of lower mortality. Patients with hyperlipidemia are normally at risk for higher mortality. Surprisingly, we found that in patients who were treated for hyperlipidemia this risk was not only diminished but also even changed into a significantly lower risk for mortality. This illustrates a significant under recognition and under treatment of hyperlipidemia.
Conclusion
Although no formal risk model for primary CABG was used, careful stratification for non-emergent treatment in a low volume, limited facility location is feasible. Using this strategy in-hospital mortality and the complication rate were low.
